These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17405579)

  • 1. Managing opioid dependence effectively in a managed care environment.
    Giaquinta D
    Manag Care Interface; 2007 Feb; 20(2):31-2, 42. PubMed ID: 17405579
    [No Abstract]   [Full Text] [Related]  

  • 2. Substance abuse treatment: outcomes of managed care techniques.
    Chung R; Filstead WJ
    Behav Healthc Tomorrow; 1995; 4(6):78-9, 58. PubMed ID: 10172617
    [No Abstract]   [Full Text] [Related]  

  • 3. Improving success with managed care on addiction-related matters.
    Alle MK
    Behav Healthc Tomorrow; 2004 Dec; 13(6):21-3, 25. PubMed ID: 15700614
    [No Abstract]   [Full Text] [Related]  

  • 4. Managed care, inter-agency linkages, and outpatient substance abuse treatment.
    Carter WC; Lee SY; Thomas KC; Morrissey J
    Adm Policy Ment Health; 2006 Jan; 33(1):122-31. PubMed ID: 16416037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving access to buprenorphine. A managed care company overcomes several obstacles to make this treatment more available.
    Nemecek D
    Behav Healthc; 2007 Nov; 27(11):40-2. PubMed ID: 18293793
    [No Abstract]   [Full Text] [Related]  

  • 6. Bringing sex and gender into women's substance use treatment programs.
    Greaves L; Poole N
    Subst Use Misuse; 2008 Jul; 43(8-9):1271-3. PubMed ID: 18649246
    [No Abstract]   [Full Text] [Related]  

  • 7. Socioeconomic analysis of addictions treatment.
    Langenbucher JW
    Public Health Rep; 1996; 111(2):135-7. PubMed ID: 8606910
    [No Abstract]   [Full Text] [Related]  

  • 8. Rehab centers run dry.
    Gleick E
    Time; 1996 Feb; 147(6):44-5. PubMed ID: 10172560
    [No Abstract]   [Full Text] [Related]  

  • 9. Processes and outcomes of substance abuse treatment between two programs for clients insured under managed care.
    McNeese-Smith D; Nyamathi A; Longshore D; Wickman M; Robertson S; Obert J; McCann M; Wells K; Wenzel SL
    Am J Drug Alcohol Abuse; 2007; 33(3):439-46. PubMed ID: 17613971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The systems approach to managing mental health and chemical dependency treatment--synergism at work.
    DiMonaco JS; DiMonaco D
    Empl Benefits J; 1989 Mar; 14(1):12-6. PubMed ID: 10318213
    [No Abstract]   [Full Text] [Related]  

  • 12. Is managed care closing substance abuse treatment units?
    Wells R; Harris Lemak C; Alexander JA; Roddy BL; Nahra TA
    Manag Care Interface; 2007 Mar; 20(3):28-32. PubMed ID: 17458479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The managed care context.
    Meyer RE
    Addiction; 2000 Dec; 95(12):1763-4. PubMed ID: 11177492
    [No Abstract]   [Full Text] [Related]  

  • 14. Insurers give substance abuse new identity: it's a disease.
    Sipkoff M
    Manag Care; 2005 Apr; 14(4):18-20, 23-4, 26. PubMed ID: 15898207
    [No Abstract]   [Full Text] [Related]  

  • 15. Do licensing and accreditation matter in outpatient substance abuse treatment programs?
    Wells R; Lemak CH; Alexander JA; Nahra TA; Ye Y; Campbell CI
    J Subst Abuse Treat; 2007 Jul; 33(1):43-50. PubMed ID: 17588488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition and management of depression in a substance use disorder treatment population.
    Curran GM; Booth BM; Kirchner JE; Deneke DE
    Am J Drug Alcohol Abuse; 2007; 33(4):563-9. PubMed ID: 17668342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organizational- and individual-level correlates of posttreatment substance use: a multilevel analysis.
    Ghose T
    J Subst Abuse Treat; 2008 Mar; 34(2):249-62. PubMed ID: 17600654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic considerations for the treatment of opioid and alcohol dependence: a managed care perspective.
    Dunn JD
    Am J Manag Care; 2011 Jun; 17 Suppl 8():S210-2. PubMed ID: 21761947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug abuse: treatment programs in hospitals.
    Barton WI
    Hospitals; 1974 Jul; 48(14):42-6. PubMed ID: 4837755
    [No Abstract]   [Full Text] [Related]  

  • 20. A profile of the substance abuse treatment industry: organization, costs, and treatment completion.
    Woodward AM; Raskin IE; Blacklow B
    Subst Use Misuse; 2008; 43(5):647-79. PubMed ID: 18393082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.